Sio Capital Management, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Sio Capital Management, LLC disclosed 73 US equity positions worth $693.9m in its Q1 2026 13F filing. The largest position was MMS at 7.1% of the reported book, followed by WAY and ICLR.
What did Sio Capital Management, LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | MMS MAXIMUS INC | Industrials | 7.1% | $49.3m | 768,825 | – | |
| 2 | WAY WAYSTAR HLDG CORP | Healthcare | 5.7% | $39.6m | 1,642,236 | – | |
| 3 | ICLR ICON PLC | Healthcare | 4.9% | $33.9m | 306,358 | – | |
| 4 | COR CENCORA INC | Healthcare | 4.6% | $31.7m | 100,894 | – | |
| 5 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 4.5% | $31.1m | 370,045 | – | |
| 6 | AVR ANTERIS TECHNOLOGIES GLOBAL | 4.3% | $29.9m | 5,382,965 | – | ||
| 7 | CORT CORCEPT THERAPEUTICS INC | Healthcare | 3.9% | $27.2m | 674,759 | – | |
| 8 | LIVN LIVANOVA PLC | Healthcare | 3.9% | $26.8m | 421,615 | – | |
| 9 | TYRA TYRA BIOSCIENCES INC | Healthcare | 3.3% | $23.2m | 605,439 | – | |
| 10 | CELC CELCUITY INC | Healthcare | 3.2% | $22.1m | 193,843 | – | |
| 11 | GSK GSK PLC | Healthcare | 3.1% | $21.3m | 385,879 | – | |
| 12 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 2.9% | $20.4m | 265,543 | – | |
| 13 | ABT ABBOTT LABORATORIES | Healthcare | 2.8% | $19.2m | 186,574 | – | |
| 14 | EMBC EMBECTA CORP | Healthcare | 2.4% | $16.3m | 1,847,850 | – | |
| 15 | ABVX ABIVAX SA | Healthcare | 2.2% | $15.1m | 135,800 | – | |
| 16 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.9% | $13.4m | 1,498,620 | – | |
| 17 | HAE HAEMONETICS CORP MASS | Healthcare | 1.8% | $12.4m | 220,672 | – | |
| 18 | SION SIONNA THERAPEUTICS INC | Healthcare | 1.7% | $11.8m | 294,340 | – | |
| 19 | SNY SANOFI SA | Healthcare | 1.7% | $11.5m | 239,671 | – | |
| 20 | RAPP RAPPORT THERAPEUTICS INC | 1.7% | $11.5m | 366,809 | – | ||
| 21 | TFX TELEFLEX INCORPORATED | Healthcare | 1.6% | $11.3m | 94,800 | – | |
| 22 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 1.6% | $11.0m | 194,226 | – | |
| 23 | CROSS CTRY HEALTHCARE INC | 1.5% | $10.3m | 1,098,393 | – | ||
| 24 | TARA PROTARA THERAPEUTICS INC | 1.5% | $10.3m | 1,969,839 | – | ||
| 25 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.5% | $10.1m | 209,093 | – | |
| 26 | BHVN BIOHAVEN LTD | Healthcare | 1.4% | $9.8m | 1,163,926 | – | |
| 27 | MNPR MONOPAR THERAPEUTICS INC | 1.4% | $9.5m | 173,506 | – | ||
| 28 | EYPT EYEPOINT INC | Healthcare | 1.3% | $9.3m | 721,785 | – | |
| 29 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 1.3% | $9.1m | 249,887 | – | ||
| 30 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 1.2% | $8.5m | 268,986 | – | |
| 31 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.2% | $8.3m | 1,506,525 | – | |
| 32 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 1.2% | $8.2m | 968,597 | – | |
| 33 | AQST AQUESTIVE THERAPEUTICS INC | 1.2% | $8.0m | 1,922,887 | – | ||
| 34 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 1.0% | $6.7m | 965,000 | – | |
| 35 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.9% | $6.5m | 132,496 | – | |
| 36 | ZBIO ZENAS BIOPHARMA INC | 0.9% | $6.5m | 331,730 | – | ||
| 37 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.9% | $6.3m | 86,083 | – | |
| 38 | QDEL QUIDELORTHO CORP | Healthcare | 0.9% | $5.9m | 359,011 | – | |
| 39 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 0.8% | $5.7m | 62,613 | – | |
| 40 | REPL REPLIMUNE GROUP INC | Healthcare | 0.8% | $5.5m | 720,036 | – | |
| 41 | OGN ORGANON & CO | Healthcare | 0.7% | $5.2m | 865,908 | – | |
| 42 | OKUR ONKURE THERAPEUTICS INC | 0.6% | $4.5m | 1,078,965 | – | ||
| 43 | IRON DISC MEDICINE INC | Healthcare | 0.6% | $4.2m | 65,203 | – | |
| 44 | PMVP PMV PHARMACEUTICALS INC | Healthcare | 0.5% | $3.8m | 3,076,580 | – | |
| 45 | IMNM IMMUNOME INC | Healthcare | 0.5% | $3.6m | 165,110 | – | |
| 46 | IART INTEGRA LIFESCIENCES HLDGS C | Healthcare | 0.5% | $3.6m | 383,140 | – | |
| 47 | SVRA SAVARA INC | Healthcare | 0.5% | $3.4m | 613,888 | – | |
| 48 | PROQR THERAPEUTICS N V | 0.5% | $3.2m | 1,954,715 | – | ||
| 49 | SI SHOULDER INNOVATIONS INC | 0.4% | $3.1m | 210,641 | – | ||
| 50 | OVID OVID THERAPEUTICS INC | Healthcare | 0.4% | $2.8m | 1,252,381 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.